首页|期刊导航|中国实验方剂学杂志|肺痹汤2号调控AT2细胞内质网应激抵抗凋亡促进肺泡修复改善小鼠肺纤维化的机制

肺痹汤2号调控AT2细胞内质网应激抵抗凋亡促进肺泡修复改善小鼠肺纤维化的机制OA

Mechanism of Number 2 Feibi Recipe in Ameliorating Pulmonary Fibrosis in Mice by Modulating Endoplasmic Reticulum Stress in AT2 Cells to Attenuate Apoptosis and Promote Alveolar Repair

中文摘要英文摘要

目的:探讨中药复方肺痹汤2号在特发性肺纤维化中的干预机制,聚焦其对肺泡Ⅱ型上皮细胞(AT2)内质网应激、凋亡、干性维持及再生修复能力的影响,验证"宗气衰微-肺泡痿痹"理论的现代转化路径.方法:采用博来霉素(BLM)诱导小鼠肺纤维化模型,设空白组,模型组与肺痹汤2号低、高剂量组(9.1、18.2g·kg-1)及醋酸波尼松龙组(6.5 mg·kg-1).通过苏木素-伊红(HE)及马松(Masson)染色评估肺组织结构变化及胶原沉积情况,采用碱水解法测量羟脯氨酸(HYP)含量,测量肺系数及肺功能指标.应用实时荧光定量聚合酶链式反应(Real-time PCR)检测纤维化相关因子[胶原蛋白Ⅰ型α1链(ColⅠ a1)、α平滑肌肌动蛋白(α-SMA)、金属蛋白酶组织抑制剂l(Timp 1)]mRNA表达水平.使用末端脱氧核苷酸转移酶介导的dUTP缺口末端标记法(TUNEL)评估细胞凋亡,表面活性蛋白C(SPC)和半胱氨酸天冬氨酸蛋白酶-3(Caspase-3)双染免疫荧光法进一步评估AT2细胞凋亡,SPC和蛋白激酶R样内质网激酶(PERK)双染检测AT2细胞内质网应激情况,透射电镜观察AT2细胞内质网及板层小体超微结构变化.通过蛋白免疫印迹法(Western blot)检测内质网应激及凋亡通路关键蛋白PERK、激活转录因子4(Atf4)及Caspase-3表达情况.通过双染免疫荧光标记SPC和Ki-67抗原(Ki-67)分析AT2细胞增殖能力,利用谱系追踪技术(GFP+小鼠)联合Krt8标记检测分化中间状态,并观察AT2细胞向肺泡Ⅰ型上皮细胞(AT1)细胞形态的转化.结果:BLM诱导后小鼠出现显著肺组织结构破坏、胶原沉积增加、肺系数升高、肺功能下降和纤维化因子上调(P<0.01).高剂量肺痹汤2号干预可显著改善肺组织损伤与功能障碍,显著降低HYP含量(P<0.01),显著下调ColⅠ a1、α-SMA、Timp1表达(P<0.01).凋亡分析显示模型组TUNEL阳性细胞比例上升,AT2细胞Caspase-3阳性率显著增加,而高剂量组显著降低.透射电镜下AT2细胞内质网结构肿胀,给药治疗后趋于正常;PERK蛋白质染色分析发现模型组AT2细胞内质网应激明显,给药组显著缓解.模型组中内质网应激相关蛋白PERK、Atf4及凋亡蛋白Caspase-3的表达升高,给药后可显著降低.透射电镜下模型组板层小体结构紊乱,治疗组趋于恢复.AT2细胞增殖能力方面,治疗组Ki-67+SPC+细胞比例显著上升(P<0.01).谱系追踪显示模型组角蛋白8阳性绿色荧光蛋白阳性(Krt8+GFP+)细胞占比升高,提示分化阻滞;治疗组该比例显著下降,同时GFP+细胞形态向扁平延展转变,提示分化向AT1方向恢复.结论:肺痹汤2号通过缓解AT2细胞内质网应激、减少AT2细胞凋亡、恢复其板层小体结构与功能、增强其增殖活性、缓解分化阻滞促进其向AT1细胞分化,从而修复肺泡有效阻断肺纤维化的进展.其"复宗气、和气血、通肺络"的中医治疗机制与现代AT2干细胞调控路径高度契合,为中药干预IPF提供了新理论与实验依据.

Objective:To investigate the intervention mechanism of the traditional Chinese medicine Number 2 Feibi recipe(N2FBR)in idiopathic pulmonary fibrosis(IPF),focusing on its effects on endoplasmic reticulum(ER)stress,apoptosis,stemness maintenance,and regenerative capacity of alveolar type Ⅱ epithelial cells(AT2 cells),and to validate the modern translational pathway of the theory of"deficiency of Zong Qi leading to pulmonary atelectasis and atrophy".Methods:A mouse model of pulmonary fibrosis was induced by bleomycin(BLM).Mice were randomly divided into blank control,model,low-,and high-dose N2FBR intervention groups(9.1,18.2 g·kg-1),and prednisolone intervention group(6.5 mg·kg-1).Pulmonary histopathological changes and collagen deposition were evaluated using hematoxylin-eosin(HE)and Masson's trichrome staining.Hydroxyproline(HYP)content was measured by the alkaline hydrolysis method.Lung coefficient and pulmonary function parameters were evaluated.The mRNA expression levels of fibrosis-related factors,including collagen type Ⅰ alpha 1 chain(ColⅠa1),alpha-smooth muscle actin(α-SMA),and tissue inhibitor of metalloproteinase 1(Timpl),were detected by real-time polymerase chain reaction(Real-time PCR).Cell apoptosis was assessed using the terminal deoxynucleotidyl transferase dUTP nick-end labeling(TUNEL)assay.Apoptosis of AT2 cells was further evaluated by double immunofluorescence staining for surfactant protein C(SPC)and cysteine-aspartic protease-3(Caspase-3).Endoplasmic reticulum(ER)stress in AT2 cells was examined by double staining for SPC and protein kinase R-like endoplasmic reticulum kinase(PERK).Ultrastructural changes of ER and lamellar bodies in AT2 cells were observed by transmission electron microscopy(TEM).The expression levels of key proteins involved in ER stress and apoptosis pathways,including PERK,activating transcription factor 4(ATF4),and Caspase-3,were detected by Western blot.Double immunofluorescence staining of SPC and Ki-67 antigen(Ki-67)was performed to evaluate the proliferative capacity of AT2 cells.Lineage tracing technology(labeling AT2 cells with GFP)combined with Krt8 labeling was used to evaluate intermediate differentiation states,and morphological transformation of AT2 cells into alveolar type Ⅰ epithelial cells(AT1)was observed.Results:BLM-induced mice exhibited significant structural disruption of lung tissue,increased collagen deposition,elevated lung coefficient,decreased pulmonary function,and upregulation of fibrosis-related factors(P<0.01).High-dose N2FBR treatment significantly ameliorated lung tissue damage and dysfunction,significantly reduced HYP content(P<0.01),and significantly downregulated ColⅠa1,α-SMA,and Timp1 expression(P<0.01).Apoptosis analysis showed increased TUNEL-positive and Caspase-3-positive AT2 cells in the model group,which was significantly reduced by high-dose N2FBR treatment.TEM revealed swollen ER structures in AT2 cells of the model group,which tended to return to normal following treatment.PERK protein staining analysis showed evident ER stress in AT2 cells of the model group,which were markedly alleviated in the treatment group.The expression levels of ER stress-related proteins PERK and ATF4,as well as the apoptosis-related protein Caspase-3,were elevated in the model group and significantly reduced after treatment.TEM also revealed disrupted lamellar body structures in the model group,which tended to recover in the treatment group.Regarding the proliferative capacity of AT2 cells,the proportion of Ki-67+SPC+AT2 cells significantly increased in the treatment group(P<0.01).Lineage tracing showed that the proportion of keratin 8-positive green fluorescent protein-positive(Krt8+GFP+)cells increased in the model group,indicating differentiation arrest.This proportion was significantly reduced in the treatment group,and the morphology of GFP+cells exhibited a flattened,extended shape,suggesting restored differentiation toward AT1 cells.Conclusion:N2FBR alleviates ER stress in AT2 cells,reduces AT2 cell apoptosis,restores lamellar body structure and function,enhances proliferation activity,and alleviates differentiation arrest to promote differentiation into AT1 cells,thereby repairing the alveolar epithelium and effectively blocking the progression of pulmonary fibrosis.Its traditional Chinese medicine mechanism of"replenishing Zong Qi,harmonizing Qi and blood,and unblocking pulmonary meridians"closely aligns with the modern regulatory pathway of AT2 stem cells,providing a novel theoretical basis and experimental evidence for the intervention of IPF with traditional Chinese medicine.

蔡耀东;贝佳凌;韦婉;徐成岩;刘艳丽;王勇;焦扬;陈云

北京中医药大学第二临床医学院,北京 100078北京中医药大学中医学院,北京 100029北京中医药大学东方医院,北京 100078北京中医药大学中医学院,北京 100029北京中医药大学中医学院,北京 100029北京中医药大学东直门医院,北京 100700北京中医药大学东方医院,北京 100078北京中医药大学中医学院,北京 100029

医药卫生

特发性肺纤维化再生阻滞凋亡内质网应激干性宗气肺痹汤2号

idiopathic pulmonary fibrosis(IPF)regenerative arrestapoptosisendoplasmic reticulum(ER)stressstemnessZong QiNumber 2 Feibi recipe

《中国实验方剂学杂志》 2026 (10)

80-92,13

国家自然科学基金项目(8220143109)北京市自然科学基金项目(7252239)中央高校基本科研业务费专项(2024-JYB-JBZD-057)

10.13422/j.cnki.syfjx.20252509

评论